Nantahala Capital Management, LLC Immatics N.V. Transaction History

Nantahala Capital Management, LLC

$1.68 Billion
Q3 2024

A detailed history of Nantahala Capital Management, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 625,659 shares of IMTX stock, worth $4.75 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

625,659

Previous 787,974 20.6%

Holding current value

$4.75 Million

Previous $9.16 Million 22.04%

% of portfolio

0.42%

Previous 0.61%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.93 - $12.92 $1.77 Million - $2.1 Million	-162,315 Reduced 20.6%	625,659 $7.14 Million
Q1 2024 May 15, 2024	SELL	$10.23 - $12.94 $6.4 Million - $8.1 Million	-625,982 Reduced 44.27%	787,974 $8.28 Million
Q4 2023 Feb 14, 2024	SELL	$7.36 - $10.89 $3.73 Million - $5.52 Million	-506,680 Reduced 26.38%	1,413,956 $14.9 Million
Q3 2023 Nov 14, 2023	SELL	$11.01 - $12.62 $4.01 Million - $4.6 Million	-364,259 Reduced 15.94%	1,920,636 $22.2 Million
Q2 2023 Aug 14, 2023	SELL	$5.92 - $12.72 $2.74 Million - $5.9 Million	-463,632 Reduced 16.87%	2,284,895 $26.4 Million
Q4 2022 Feb 14, 2023	BUY	$8.05 - $11.58 $278,199 - $400,193	34,559 Added 1.27%	2,748,527 $23.9 Million
Q3 2022 Nov 10, 2022	SELL	$3.31 - $13.06 $1.35 Million - $5.33 Million	-407,791 Reduced 13.06%	2,713,968 $27.1 Million
Q2 2022 Aug 15, 2022	BUY	$6.0 - $9.37 $1.06 Million - $1.66 Million	177,100 Added 6.01%	3,121,759 $27.2 Million
Q1 2022 May 13, 2022	BUY	$6.64 - $12.85 $172,620 - $334,061	25,997 Added 0.89%	2,944,659 $23.5 Million
Q4 2021 Feb 14, 2022	BUY	$10.81 - $14.38 $2.93 Million - $3.9 Million	271,213 Added 10.24%	2,918,662 $39.2 Million
Q3 2021 Nov 15, 2021	BUY	$11.58 - $15.46 $1.19 Million - $1.59 Million	102,827 Added 4.04%	2,647,449 $34.4 Million
Q2 2021 Aug 16, 2021	BUY	$10.43 - $12.81 $1.07 Million - $1.32 Million	102,857 Added 4.21%	2,544,622 $29.5 Million
Q1 2021 May 14, 2021	SELL	$10.24 - $14.6 $744,693 - $1.06 Million	-72,724 Reduced 2.89%	2,441,765 $27.4 Million
Q4 2020 Feb 16, 2021	SELL	$9.67 - $12.05 $1.04 Million - $1.3 Million	-107,675 Reduced 4.11%	2,514,489 $27.1 Million
Q3 2020 Nov 16, 2020	BUY	$8.73 - $15.15 $22.9 Million - $39.7 Million	2,622,164 New	2,622,164 $27 Million

Others Institutions Holding IMTX

# of Institutions

101

Shares Held

75.8M

Call Options Held

238K

Put Options Held

727K

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $579M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account

Nantahala Capital Management, LLC Immatics N.V. Transaction History